CME Group (NASDAQ: CME) reported Q4 EPS of $1.39, $0.03 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.

"As the ongoing global pandemic created an environment of extreme uncertainty and market volatility, we remained highly focused on helping our clients manage risk that was impacting their businesses," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Despite the challenges, we achieved record international volume during full-year 2020 and saw strong, double-digit, year-over-year growth in the fourth quarter across our Equity Index and Agricultural businesses. Since the start of 2021, we completed the migration of our BrokerTec business to CME Globex, unlocking additional value and cost efficiencies for our clients who can now access listed derivatives, cash and repo markets on a common platform. Looking ahead, we will continue to deliver innovative products that can address our clients' evolving needs, including Q1 launches for Ether futures, Global Emissions Offset futures and Japanese energy futures."

For earnings history and earnings-related data on CME Group (CME) click here.